Discovering a Path to FREEDOM
Автор: Talaris
Загружено: 2022-09-26
Просмотров: 28
Suzanne Ildstad, MD, Senior Scientific Advisor and Founder, Talaris Therapeutics, shares her passion to discover therapies to eliminate toxic immunosuppressive medicines following a living donor kidney transplant. Dr. Ildstad’s passion led to the development of an investigational cell therapy, FCR001. The goal of the FREEDOM-1 trial is to determine if FCR001 can induce durable immune tolerance to the transplanted kidney without dependence on chronic immunosuppressive medicines to prevent graft rejection.
#immunetolerance #livingdonor #kidneytransplant
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: